← Browse by Condition
Medical Condition
mantle cell lymphoma mcl
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2
NCT07257510
Recruiting
Pomalidomide Plus Orelabrutinib and Zuberitamab in Untreated Mantle Cell Lymphoma
Enrollment
34 pts
Location
China
Sponsor
Peking University Third Hospit...
NCT07272499 Phase 2
Recruiting
Orelabrutinib Plus Lisaftoclax and Rituximab in Untreated Mantle Cell Lymphoma With High-Risk Disease
Enrollment
25 pts
Location
China
Sponsor
Ruijin Hospital